870543-50-3

Upstream product

• 870543-53-6 4-Oxo-pentanoic acid (2S,3R,4S,5R,6R)-2-[(2S,3R,4R,5S,6S)-3-acetoxy-5-benzyloxy-2-(4-methoxy-phenoxy)-6-methyl-tetrahydro-pyran-4-yloxy]-5-azido-4-benzyloxy-6-methyl-tetrahydro-pyran-3-yl ester 
• 870543-37-6 p-methoxyphenyl 2-O-acetyl-4-O-benzyl-α-L-rhamnopyranoside 

Downstream Products

• 870543-42-3 4-azido-3-O-benzyl-4,6-dideoxy-2-O-methyl-β-D-glucopyranosyl-(1->3)-2-O-acetyl-4-O-benzyl-α-L-rhamnopyranosyl trichloroacetimidate 
• 870543-43-4 4-penten-1-yl 4-azido-3-O-benzyl-4,6-dideoxy-2-O-methyl-β-D-glucopyranosyl-(1->3)-2-O-acetyl-4-O-benzyl-α-L-rhamnopyranosyl-(1->3)-2-O-acetyl-4-O-benzyl-α-L-rhamnopyranosyl-(1->2)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
• 870543-41-2 4-methoxyphenyl 4-azido-3-O-benzyl-4,6-dideoxy-2-O-methyl-β-D-glucopyranosyl-(1->3)-2-O-acetyl-4-O-benzyl-α-L-rhamnopyranoside 

Relevant academic research and scientific papers

Total synthesis of antigen Bacillus anthracis tetrasaccharide - Creation of an anthrax vaccine candidate

Fighting Anthrax by recognizing its coat: The spores of Bacillus anthracis bear unique oligosaccharides on their surface for interaction with a host. These specific oligosaccharides may prove useful in the development of vaccines against this major biowar